Retour
26
19
50
37
Fourchette du Jour
51,95 €
54,00 €
Fourchette 52 Semaines
51,95 €
172,95 €
Volume
779 960
Moyenne 50J / 200J
70,58 €
/
94,45 €
Clôture Précédente
53,72 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 10,4 | 0,4 |
| P/B | 1,9 | 2,9 |
| ROE % | 19,8 | 3,8 |
| Net Margin % | 16,0 | 3,9 |
| Rev Growth 5Y % | 40,6 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
97,50 €
+86.9%
Low: 60,00 €
High: 180,00 €
P/E Prévisionnel
27,1
BPA Prévisionnel
1,92 €
Croissance BPA (est.)
+0,0%
CA Est.
970 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
5,21 €
4,97 € – 5,47 €
|
1,4 B | 1 |
| FY2029 |
4,24 €
4,05 € – 4,46 €
|
1,3 B | 1 |
| FY2028 |
3,39 €
2,77 € – 4,51 €
|
1,1 B | 5 |
Points Clés
Revenue grew 40,60% annually over 5 years — strong growth
Earnings grew 171,77% over the past year
ROE of 19,77% — decent returns on equity
Net margin of 15,95% shows strong profitability
Debt/Equity of 0,04 — conservative balance sheet
Generating 78,48M in free cash flow
Croissance
Revenue Growth (5Y)
40,60%
Revenue (1Y)13,60%
Earnings (1Y)171,77%
FCF Growth (3Y)775,43%
Qualité
Return on Equity
19,77%
ROIC4,70%
Net Margin15,95%
Op. Margin5,59%
Sécurité
Debt / Equity
0,04
Current Ratio6,08
Interest Coverage371,93
Valorisation
P/E Ratio
10,42
P/B Ratio1,94
EV/EBITDA28,32
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,60% | Revenue Growth (3Y) | 20,82% |
| Earnings Growth (1Y) | 171,77% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 40,60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 911,98M | Net Income (TTM) | 145,42M |
| ROE | 19,77% | ROA | 16,03% |
| Gross Margin | 85,39% | Operating Margin | 5,59% |
| Net Margin | 15,95% | Free Cash Flow (TTM) | 78,48M |
| ROIC | 4,70% | FCF Growth (3Y) | 775,43% |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 6,08 |
| Interest Coverage | 371,93 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 10,42 | P/B Ratio | 1,94 |
| P/S Ratio | 1,66 | PEG Ratio | 0,11 |
| EV/EBITDA | 28,32 | Dividend Yield | 0,00% |
| Market Cap | 1,52B | Enterprise Value | 1,44B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 911,98M | 802,80M | 624,80M | 407,86M | 233,39M |
| Net Income | 145,42M | 53,51M | -21,15M | -44,88M | -42,04M |
| EPS (Diluted) | 4,89 | 1,75 | -0,72 | -1,60 | -1,54 |
| Gross Profit | 778,76M | 679,82M | 528,22M | 341,74M | 200,12M |
| Operating Income | 50,95M | 36,08M | -40,27M | -47,59M | -39,85M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 907,32M | 808,38M | 676,81M | 564,88M | 295,08M |
| Total Liabilities | 126,16M | 118,69M | 104,30M | 68,87M | 66,04M |
| Shareholders' Equity | 781,16M | 689,70M | 572,51M | 496,01M | 229,05M |
| Total Debt | 32,16M | 31,79M | 24,85M | 16,41M | 34,10M |
| Cash & Equivalents | 104,81M | 150,15M | 185,54M | 441,59M | 214,47M |
| Current Assets | 583,65M | 630,81M | 593,74M | 530,03M | 268,54M |
| Current Liabilities | 96,06M | 88,50M | 78,11M | 61,19M | 41,31M |
Scores de Stratégies
This stock passed the criteria for 4 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#176 of 213
#422 of 658
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#173 of 326
Custom
Lower Risk
#105 of 136
Activité Récente
Entré
Capital Light Compounder
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Entré
Lower Risk
Mar 24, 2026